BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 33761287)

  • 21. Low-dose melittin is safe for intravitreal administration and ameliorates inflammation in an experimental model of uveitis.
    Moreira Castro BF; Nunes da Silva C; Barbosa Cordeiro LP; Pereira de Freitas Cenachi S; Vasconcelos-Santos DV; Machado RR; Dias Heneine LG; Silva LM; Silva-Cunha A; Fialho SL
    Curr Res Pharmacol Drug Discov; 2022; 3():100107. PubMed ID: 35647524
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intravitreal ketamine promotes neuroprotection in rat eyes after experimental ischemia.
    Dourado LFN; Oliveira LG; da Silva CN; Toledo CR; Fialho SL; Jorge R; Silva-Cunha A
    Biomed Pharmacother; 2021 Jan; 133():110948. PubMed ID: 33249278
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo release and retinal safety of intravitreal implants of thalidomide in rabbit eyes and antiangiogenic effect on the chorioallantoic membrane.
    Fialho SL; Souza PA; Fulgêncio GO; Miranda MM; Pereira BG; Haddad A; Messias A; Jorge R; Silva-Cunha A
    J Drug Target; 2013 Nov; 21(9):837-45. PubMed ID: 23952807
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Toxicity Evaluation of a Novel Rapamycin Liposomal Formulation After Subconjunctival and Intravitreal Injection.
    Salas-Ambrosio PJ; Bernad-Bernad MJ; Linares-Alba MA; García-Santisteban R; Tonix-Aburto LA; Ornelas-Lobato GJ; Gracia-Mora I; Rivera-Huerta M; Sánchez-Bartez F; Rico-Morales H; García-Sánchez GA
    J Ocul Pharmacol Ther; 2021 Jun; 37(5):261-276. PubMed ID: 33691483
    [No Abstract]   [Full Text] [Related]  

  • 25. Intravitreal injection of bevacizumab induces inflammatory alterations in a uveitis experimental model.
    Johnsen-Soriano S; Arnal E; Sancho-Tello M; Muriach M; Almansa I; Bosch-Morell F; Navea A; Romero FJ
    Eur J Ophthalmol; 2011; 21(4):427-33. PubMed ID: 21038308
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Poly(ortho ester) nanoparticles targeted for chronic intraocular diseases: ocular safety and localization after intravitreal injection.
    Li H; Palamoor M; Jablonski MM
    Nanotoxicology; 2016 Oct; 10(8):1152-9. PubMed ID: 27108911
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Intravitreal triamcinolone acetonide for the treatment of intraocular edematous and neovascular diseases].
    Jonas JB; Kreissig I; Kamppeter B; Degenring RF
    Ophthalmologe; 2004 Feb; 101(2):113-20. PubMed ID: 14991306
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ultrathin Polyimide Membrane as Cell Carrier for Subretinal Transplantation of Human Embryonic Stem Cell Derived Retinal Pigment Epithelium.
    Ilmarinen T; Hiidenmaa H; Kööbi P; Nymark S; Sorkio A; Wang JH; Stanzel BV; Thieltges F; Alajuuma P; Oksala O; Kataja M; Uusitalo H; Skottman H
    PLoS One; 2015; 10(11):e0143669. PubMed ID: 26606532
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dye solutions based on lutein and zeaxanthin: in vitro and in vivo analysis of ocular toxicity profiles.
    Casaroli-Marano RP; Sousa-Martins D; Martínez-Conesa EM; Badaró E; Nunes RP; Lima-Filho AA; Rodrigues EB; Belfort R; Maia M
    Curr Eye Res; 2015 Jul; 40(7):707-18. PubMed ID: 25153042
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The safety, pharmacokinetics, and efficacy of intraocular celecoxib.
    Kim SJ; Toma H; Shah R; Kompella UB; Vooturi SK; Sheng J
    Invest Ophthalmol Vis Sci; 2014 Mar; 55(3):1409-18. PubMed ID: 24458149
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A safety study of high concentration and high frequency intravitreal injection of conbercept in rabbits.
    Wang J; Lei C; Tao L; Wu Q; Ke X; Qiu Y; Lei B
    Sci Rep; 2017 Apr; 7(1):592. PubMed ID: 28377591
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-Inflammatory Effect of Dexamethasone Controlled Released From Anterior Suprachoroidal Polyurethane Implants on Endotoxin-Induced Uveitis in Rats.
    Barbosa Saliba J; Vieira L; Fernandes-Cunha GM; Rodrigues Da Silva G; Ligório Fialho S; Silva-Cunha A; Bousquet E; Naud MC; Ayres E; Oréfice RL; Tekaya M; Kowalczuk L; Zhao M; Behar-Cohen F
    Invest Ophthalmol Vis Sci; 2016 Apr; 57(4):1671-9. PubMed ID: 27054520
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ocular safety of infliximab in rabbit and cell culture models.
    Giansanti F; Papucci L; Capaccioli S; Bacherini D; Vannozzi L; Witort E; Menchini U
    J Ocul Pharmacol Ther; 2010 Feb; 26(1):65-71. PubMed ID: 20148652
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Infliximab exerts a dose-dependent effect on retinal safety in the albino rabbit.
    Zayit-Soudry S; Vainer I; Zemel E; Mimouni M; Rabena M; Pieramici DJ; Perlman I; Loewenstein A
    Doc Ophthalmol; 2017 Dec; 135(3):175-185. PubMed ID: 28825191
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intravitreal sustained-release cyclosporine in the treatment of experimental uveitis.
    Jaffe GJ; Yang CS; Wang XC; Cousins SW; Gallemore RP; Ashton P
    Ophthalmology; 1998 Jan; 105(1):46-56. PubMed ID: 9442778
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapeutic potential of a monoclonal antibody blocking the Wnt pathway in diabetic retinopathy.
    Lee K; Hu Y; Ding L; Chen Y; Takahashi Y; Mott R; Ma JX
    Diabetes; 2012 Nov; 61(11):2948-57. PubMed ID: 22891217
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel imidazopyridine derivative, X22, prevents the retinal ischemia-reperfusion injury via inhibition of MAPKs.
    Bian Y; Ren L; Wang L; Xu S; Tao J; Zhang X; Huang Y; Qian Y; Zhang X; Song Z; Wu W; Wang Y; Liang G
    Exp Eye Res; 2015 Jun; 135():26-36. PubMed ID: 25907396
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The efficacy of systemic and intravitreal infliximab treatments in an endotoxin-induced uveitis model.
    Donmez O; Yaman A; Ozturk T; Aktas S; Altun ZS; Yılmaz O
    Cutan Ocul Toxicol; 2019 Dec; 38(4):360-369. PubMed ID: 31213109
    [No Abstract]   [Full Text] [Related]  

  • 39. Expert Opinion on Management of Intraocular Inflammation, Retinal Vasculitis, and Vascular Occlusion after Brolucizumab Treatment.
    Baumal CR; Bodaghi B; Singer M; Tanzer DJ; Seres A; Joshi MR; Feltgen N; Gale R
    Ophthalmol Retina; 2021 Jun; 5(6):519-527. PubMed ID: 33007521
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparison of intravitreal bevacizumab and steroid activity in an experimental uveitis model.
    Ayyıldız O; Durukan AH; Ozgurtas T; Gunal A
    Curr Eye Res; 2015; 40(12):1261-8. PubMed ID: 25546479
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.